Literature DB >> 23053995

Toll-like receptor 3: implications for proinflammatory microenvironment in human breast cancer.

Marla Karine Amarante1, Karen Brajão de Oliveira, Roberta Losi Guembarovski, Ana Cristina da Silva do Amaral Herrera, Alda Losi Guembarovski, Walter Jorge Sobrinho, Julio Cesar Voltarelli, Maria Angelica Ehara Watanabe.   

Abstract

Under many circumstances, the host constituents that are found in the tumor microenvironment support a malignancy network and provide the cancer cells with advantages in proliferation, invasiveness and metastasis establishment at remote organs. It is known that Toll like receptors (TLRs) are expressed not only on immune cells but also on cancer cells and it has suggested a deleterious role for TLR3 in inflammatory disease. Hypothesizing that altered IFNγ signaling may be a key mechanism of immune dysfunction common to cancer as well CXCR4 is overexpressed among breast cancer patients, the mRNA expression of TLR3, CXCR4 and IFNγ in breast cancer tumor tissues was investigated. No statistically significant differences in the expression of CXCR4 mRNA, IFNγ and TLR3 between healthy and tumor tissues was observed, however, it was verified a positive correlation between mRNA relative expression of TLR3 and CXCR4 (p < 0.001), and mRNA relative expression of TLR3 was significantly increased in breast cancer tumor tissue when compared to healthy mammary gland tissue among patients expressing high IFNγ (p = 0.001). Since the tumor microenvironment plays important roles in cancer initiation, growth, progression, invasion and metastasis, it is possible to propose that an overexpression of IFNγ mRNA due to the pro-inflammatory microenvironment can lead to an up-regulation of CXCR4 mRNA and consequently to an increased TLR3 mRNA expression even among nodal negative patients. In the future, a comprehensive study of TLR3, CXCR4 and IFNγ axis in primary breast tumors and corresponding healthy tissues will be crucial to further understanding of the cancer network.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23053995     DOI: 10.1007/s11033-012-2013-1

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  37 in total

Review 1.  Evolution, stress, and longevity.

Authors:  T L Kirkwood; P Kapahi; D P Shanley
Journal:  J Anat       Date:  2000-11       Impact factor: 2.610

Review 2.  Toll-like receptor 3: involvement with exogenous and endogenous RNA.

Authors:  Marla Karine Amarante; Maria Angelica Ehara Watanabe
Journal:  Int Rev Immunol       Date:  2010-12       Impact factor: 5.311

3.  Damage associated molecular pattern molecules.

Authors:  Michael T Lotze; Albert Deisseroth; Anna Rubartelli
Journal:  Clin Immunol       Date:  2007-04-30       Impact factor: 3.969

4.  Cytokine receptor CXCR4 mediates estrogen-independent tumorigenesis, metastasis, and resistance to endocrine therapy in human breast cancer.

Authors:  Lyndsay V Rhodes; Sarah P Short; Nicole F Neel; Virgilio A Salvo; Yun Zhu; Steven Elliott; Yongkun Wei; Dihua Yu; Menghong Sun; Shannon E Muir; Juan P Fonseca; Melyssa R Bratton; Chris Segar; Syreeta L Tilghman; Tammy Sobolik-Delmaire; Linda W Horton; Snjezana Zaja-Milatovic; Bridgette M Collins-Burow; Scott Wadsworth; Barbara S Beckman; Charles E Wood; Suzanne A Fuqua; Kenneth P Nephew; Paul Dent; Rebecca A Worthylake; Tyler J Curiel; Mien-Chie Hung; Ann Richmond; Matthew E Burow
Journal:  Cancer Res       Date:  2010-12-01       Impact factor: 12.701

5.  Poly I:C prevents T cell-mediated hepatitis via an NK-dependent mechanism.

Authors:  Jing Wang; Rui Sun; Haiming Wei; Zhongjun Dong; Bin Gao; Zhigang Tian
Journal:  J Hepatol       Date:  2005-09-21       Impact factor: 25.083

Review 6.  The role of epithelial Toll-like receptor signaling in the pathogenesis of intestinal inflammation.

Authors:  Steven C Gribar; Rahul J Anand; Chhinder P Sodhi; David J Hackam
Journal:  J Leukoc Biol       Date:  2007-12-26       Impact factor: 4.962

Review 7.  Naturally occurring nucleoside modifications suppress the immunostimulatory activity of RNA: implication for therapeutic RNA development.

Authors:  Katalin Karikó; Drew Weissman
Journal:  Curr Opin Drug Discov Devel       Date:  2007-09

8.  Detection and clinical implications of early systemic tumor cell dissemination in breast cancer.

Authors:  Klaus Pantel; Volkmar Müller; Margherita Auer; Nathalie Nusser; Nadia Harbeck; Stephan Braun
Journal:  Clin Cancer Res       Date:  2003-12-15       Impact factor: 12.531

Review 9.  Molecular characterisation of the tumour microenvironment in breast cancer.

Authors:  Min Hu; Kornelia Polyak
Journal:  Eur J Cancer       Date:  2008-11-19       Impact factor: 9.162

Review 10.  Interferon-gamma: an overview of signals, mechanisms and functions.

Authors:  Kate Schroder; Paul J Hertzog; Timothy Ravasi; David A Hume
Journal:  J Leukoc Biol       Date:  2003-10-02       Impact factor: 4.962

View more
  4 in total

1.  Toll-like receptor 3 (TLR3) functions as a pivotal target in latent membrane protein 1 (LMP1)-mediated nasopharyngeal carcinoma cell proliferation.

Authors:  Liang Zhou; Xiaoling Hang; Lei Xie
Journal:  Int J Clin Exp Pathol       Date:  2020-02-01

Review 2.  Roles of Toll-Like Receptor 3 in Human Tumors.

Authors:  Xin Zheng; Song Li; Hui Yang
Journal:  Front Immunol       Date:  2021-04-27       Impact factor: 7.561

3.  CIBERSORT analysis of TCGA and METABRIC identifies subgroups with better outcomes in triple negative breast cancer.

Authors:  Kelly E Craven; Yesim Gökmen-Polar; Sunil S Badve
Journal:  Sci Rep       Date:  2021-02-25       Impact factor: 4.379

4.  Expression profile of Toll‑like receptors in human breast cancer.

Authors:  Shuxun Shi; Cong Xu; Xiaonan Fang; Yonghuan Zhang; Hua Li; Wujun Wen; Guiwen Yang
Journal:  Mol Med Rep       Date:  2019-11-26       Impact factor: 2.952

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.